Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB.

Proceedings of the National Academy of Sciences of the United States of America2018Yan R, Zhang J, Park HJ, et al.

Study designOther primary literature

SubjectAnimal

Record checks

Study design: Other primary literature
Subject: Animal
Publication year: 2018
Source: doi.org
Abstract display: Not reproduced here
Publication status: Active
Status checked: 17 Aug 2026
Collected: 3 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Published

How to read this record →

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

AnimalsBrainCaffeineCoffeeDisease Models, AnimalFatty AcidsLewy Body DiseaseMiceMice, Inbred C57BLMice, TransgenicNeuronsNeuroprotectionParkinson DiseasePhosphorylationProtein Phosphatase 2Serotoninalpha-Synuclein

DOI 10.1073/pnas.1813365115

PMID 30509990

View source →